In this paper we report on three different hydrophilic copolymers based on R,-polyaspartylhydrazide (PAHy) bearing butyric groups in the side chain (C4) (PAHy-C4) or a combination of butyric groups and positive charged residues ((carboxypropyl)trimethylammonium chloride, CPTACl) (PAHy-C4-CPTA) that were synthesized and used for the preparation of new supramolecular vesicular aggregates (SVAs) containing gemcitabine as an antitumor drug. Gemcitabine-loaded SVAs containing synthesized PAHy derivatives were characterized from the physicochemical and technological point of view and the in vitro toxicity and anticancer activity on two different human cancer cell lines, i.e., CaCo-2 (human colon carcinoma) and ARO (human anaplastic thyroid carcinoma) cells, were also evaluated. Moreover, considering that carrier-cell interaction is an important factor to achieve an improvement of anticancer drug activity, confocal laser scanning microscopy and flow cytometric experiments were carried out on the two different cancer cell lines.

PAOLINO D, COSCO D, LICCIARDI M, GIAMMONA G, FRESTA M, CAVALLARO G (2008). Polyaspartylhydrazide copolymer-based supramolecular vesicular aggregates as delivery devices for anticancer drugs. BIOMACROMOLECULES, 9, 1117-1130 [10.1021/bm700964a].

Polyaspartylhydrazide copolymer-based supramolecular vesicular aggregates as delivery devices for anticancer drugs

LICCIARDI, Mariano;GIAMMONA, Gaetano;CAVALLARO, Gennara
2008-01-01

Abstract

In this paper we report on three different hydrophilic copolymers based on R,-polyaspartylhydrazide (PAHy) bearing butyric groups in the side chain (C4) (PAHy-C4) or a combination of butyric groups and positive charged residues ((carboxypropyl)trimethylammonium chloride, CPTACl) (PAHy-C4-CPTA) that were synthesized and used for the preparation of new supramolecular vesicular aggregates (SVAs) containing gemcitabine as an antitumor drug. Gemcitabine-loaded SVAs containing synthesized PAHy derivatives were characterized from the physicochemical and technological point of view and the in vitro toxicity and anticancer activity on two different human cancer cell lines, i.e., CaCo-2 (human colon carcinoma) and ARO (human anaplastic thyroid carcinoma) cells, were also evaluated. Moreover, considering that carrier-cell interaction is an important factor to achieve an improvement of anticancer drug activity, confocal laser scanning microscopy and flow cytometric experiments were carried out on the two different cancer cell lines.
2008
PAOLINO D, COSCO D, LICCIARDI M, GIAMMONA G, FRESTA M, CAVALLARO G (2008). Polyaspartylhydrazide copolymer-based supramolecular vesicular aggregates as delivery devices for anticancer drugs. BIOMACROMOLECULES, 9, 1117-1130 [10.1021/bm700964a].
File in questo prodotto:
File Dimensione Formato  
bm700964a.pdf

Solo gestori archvio

Descrizione: pdf
Dimensione 2.23 MB
Formato Adobe PDF
2.23 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/38179
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 36
  • ???jsp.display-item.citation.isi??? 33
social impact